CTRI/2021/11/037842
Not yet recruiting
未知
Dosimetric Comparison of Stereotactic Radiotherapy (SRT) Treatment plan with and without the use of Micro Multileaf Collimator (mMLC)
RECHAL NISHA DSOUZA0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: R688- Other general symptoms and signs
- Sponsor
- RECHAL NISHA DSOUZA
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •CT scans of patients undergoing SRT treatment.
Exclusion Criteria
- •Patients unfit for Radiation therapy and being considered for hypofractionated brachytherapy procedures
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Comparison between stereotactic body radiotherapy and transcatheter arterial chemoembolization for hepatocellular carcinoma: Meta-analysis and systematic review.JPRN-UMIN000051712Yokohama City University Medical Center
Recruiting
Phase 1
Phase I/II study of stereotactic radiotherapy for renal cell cancerJPRN-UMIN000004172niversity of Yamanashi30
Completed
Phase 2
Phase II study of stereotactic radiotherapy with volumetric modulated arc therapy for primary lung cancer located adjacent to organ at riskJPRN-UMIN000022856Department of Radiuation Oncology, Tohoku University Graduate School of Medicine15
Active, not recruiting
Phase 2
Stereotactic Radiotherapy for Oligoprogressive ER-positive Breast Cancer. AVATAR.Breast CancerER-positive, HER2-negative advanced breast cancerAdvanced breast cancerCancer - BreastACTRN12620001212943Peter Mac Callum Cancer Centre32
Recruiting
Phase 1
Phase I study of postoperative stereotactic body radiotherapy for prostate cancerJPRN-jRCT1030220062Yamashita Hideomi36